Anthem limiting Spinraza coverage

In a coverage policy note, Anthem Inc. (NYSE:ANTM) said Spinraza nusinersen from Biogen Inc. (NASDAQ:BIIB) is "medically necessary" to

Read the full 196 word article

User Sign In